These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 18975421)

  • 1. No unfair advantage. Medicare plans say they're ready for the new rules.
    Lubell J
    Mod Healthc; 2008 Oct; 38(42):42, 44. PubMed ID: 18975421
    [No Abstract]   [Full Text] [Related]  

  • 2. Medicare program: Medicare Advantage and Prescription Drug Benefit programs: final marketing provisions. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2008 Sep; 73(182):54207-23. PubMed ID: 18985950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicare Program; revisions to the Medicare Advantage and Prescription Drug Benefit programs. Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2008 Sep; 73(182):54225-54. PubMed ID: 18985953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicare HMO marketing and information: keeping the focus on what consumers need.
    States Health; 1999 Apr; 9(1):1-10. PubMed ID: 11503889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Six tips for Medicare marketing.
    Snyder LS; Fingold HI
    Healthplan; 1996; 37(5):19, 22-6. PubMed ID: 10161661
    [No Abstract]   [Full Text] [Related]  

  • 6. Medicare Part D: how do vulnerable beneficiaries fare?
    Summer L; Nemore P; Finberg J
    Issue Brief (Commonw Fund); 2008 Apr; 35():1-11. PubMed ID: 18536146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selling the sizzle.
    BeSaw L
    Tex Med; 1997 Sep; 93(9):33-7. PubMed ID: 9786799
    [No Abstract]   [Full Text] [Related]  

  • 8. Medicare program; Medicare prescription drug discount card; revision of marketing rules for endorsed drug card sponsors. Final rule.
    Centers for Medicare & Medicaid Services, HHS
    Fed Regist; 2005 Sep; 70(169):52019-23. PubMed ID: 16138430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicare program; revisions to the Medicare Advantage and prescription drug benefit programs: clarification of compensation plans. Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2008 Nov; 73(221):67406-14. PubMed ID: 19137670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health plans undaunted by Medicare Part D.
    Sipkoff M
    Manag Care; 2005 May; 14(5):14, 17. PubMed ID: 15962819
    [No Abstract]   [Full Text] [Related]  

  • 11. Plans enjoy short red light. But lifting marketing ban has advocates concerned.
    DoBias M
    Mod Healthc; 2007 Oct; 37(39):14. PubMed ID: 17960715
    [No Abstract]   [Full Text] [Related]  

  • 12. For PSOs, it's ... ready, set, go!
    Weissenstein E
    Mod Healthc; 1997 Nov; 27(47):34-6. PubMed ID: 10174834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plans, PBMs, pharmacy jockey for part D positioning. Are pharmacies raising rates for health plans?
    Med Health; 2005 Jun; 59(20):1-2. PubMed ID: 16021969
    [No Abstract]   [Full Text] [Related]  

  • 14. Medicare program; Medicare Part D claims data. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2008 May; 73(103):30663-85. PubMed ID: 18605408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Part D shuffle. UnitedHealth, Humana lose business.
    Vesely R
    Mod Healthc; 2007 Oct; 37(40):17. PubMed ID: 18018374
    [No Abstract]   [Full Text] [Related]  

  • 16. Toward a rational, value-based drug benefit for Medicare.
    Lopert R; Moon M
    Health Aff (Millwood); 2007; 26(6):1666-73. PubMed ID: 17978385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are you ready for Medicare Part D?
    Biola H
    Fam Pract Manag; 2006 Jan; 13(1):58-62. PubMed ID: 16457465
    [No Abstract]   [Full Text] [Related]  

  • 18. 10 initiatives may ensure uninterrupted drug coverage for dual eligibles.
    Med Health; 2005 Dec; 59(45):2. PubMed ID: 16372742
    [No Abstract]   [Full Text] [Related]  

  • 19. The $150 billion swindle. The case against Medicare Advantage is overwhelming; when will D.C. get wise?
    Sloane T
    Mod Healthc; 2007 Sep; 37(37):17. PubMed ID: 17958047
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2009 Jan; ():1-26. PubMed ID: 19301435
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.